Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Original Research

Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study

       
Total article views   HTML views PDF downloads Totals
10,534 Dovepress* 8,493+ 1,403 9,896
PubMed Central* 2,041 359 2,400
Totals 10,534 1,762 12,296
*Since 6 December 2018

View citations on PubMed Central and Google Scholar